Tvardi Therapeutics Awarded “Most Promising” Company at the 2020 Texas Life Science Forum
Gravida ultricies interdum risus adipiscing non. Ornare leo eu imperdiet.
Oncoheroes Biosciences’ Pediatric Cancer Drug Candidate Receives Orphan Drug Designation
Gravida ultricies interdum risus adipiscing non. Ornare leo eu imperdiet.
Congratulations to our Top Two Finalists and the People’s Choice Award Winner!
Gravida ultricies interdum risus adipiscing non. Ornare leo eu imperdiet.
Support Women Scientist-Entrepreneurs in Celebration of the Women’s Equality Day
Gravida ultricies interdum risus adipiscing non. Ornare leo eu imperdiet.
AIM-HI Portfolio Company Profile: Rasio Therapeutics
Gravida ultricies interdum risus adipiscing non. Ornare leo eu imperdiet.
AIM-HI Announces Semi-Finalists in Women’s Venture Competition, Finalists Announced Sept. 24
Gravida ultricies interdum risus adipiscing non. Ornare leo eu imperdiet.
AIM-HI Portfolio Company Profile: Tvardi Therapeutics
Gravida ultricies interdum risus adipiscing non. Ornare leo eu imperdiet.
Tvardi’s TTI-101 Receives $5 Million in Funding to Support Clinical Trials and Translational Research
Gravida ultricies interdum risus adipiscing non. Ornare leo eu imperdiet.
AIM-HI Portfolio Company Profile: InterLeukin Combinatorial Therapies
Gravida ultricies interdum risus adipiscing non. Ornare leo eu imperdiet.
Meet Rose Wang
Gravida ultricies interdum risus adipiscing non. Ornare leo eu imperdiet.
